Medios AG (ETR:ILM1)

Market Cap	318.36M
Revenue (ttm)	1.89B
Net Income (ttm)	12.55M
Shares Out	25.51M
EPS (ttm)	0.51
PE Ratio	24.47
Forward PE	10.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,928
Average Volume	51,544
Open	12.40
Previous Close	12.44
Day's Range	12.34 - 12.54
52-Week Range	11.24 - 18.50
Beta	1.07
RSI	46.60
Earnings Date	Mar 28, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 515
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.89 billion, an increase of 5.68% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.